Marshall Islands vs South-East Asia (WHO region): HIV-positive TB patients on ART (antiretroviral therapy)
Marshall Islands
100.0%
in 2019
South-East Asia (WHO region)
94.0%
in 2024
Marshall Islands rank
1st
South-East Asia (WHO region) rank
4th
HIV-positive TB patients on ART (antiretroviral therapy) over time
- Marshall Islands
- South-East Asia (WHO region)
How they compare
Marshall Islands currently reports 100.0% against 94.0% in South-East Asia (WHO region), a difference of 6.0%.
That makes Marshall Islands's figure about 1.1 times South-East Asia (WHO region)'s.
Across all 5 years both countries report, Marshall Islands has been ahead every year.
Marshall Islands ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
Marshall Islands has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Marshall Islands | South-East Asia (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 100.0% | 50.0% | 50.0% | Marshall Islands |
| 2010s | 100.0% | 78.5% | 21.5% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv-positive tb patients on art (antiretroviral therapy), Marshall Islands or South-East Asia (WHO region)?
- Marshall Islands, at 100.0% against 94.0% in South-East Asia (WHO region) as of 2019.
- What is the difference in hiv-positive tb patients on art (antiretroviral therapy) between Marshall Islands and South-East Asia (WHO region)?
- 6.0%, with Marshall Islands ahead.
- How many years of comparable data are there for Marshall Islands and South-East Asia (WHO region)?
- 5 years are reported by both, from 2009 to 2019.
- How do Marshall Islands and South-East Asia (WHO region) rank globally for hiv-positive tb patients on art (antiretroviral therapy)?
- Marshall Islands ranks 1st and South-East Asia (WHO region) ranks 4th of 144 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as HIV-positive TB patients on ART (antiretroviral therapy) (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.